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ABSTRACT 
 
Objective: The aim of the study was to investigate the prophylactic effects of 
acetyl L-carnitine against to uterus induced by cisplatin.  
Methods: Twenty-four female Wistar albino rats were divided into four groups: 
group I (control) was administered with saline; group II was administered with 
acetyl L-carnitine; group III was administered with cisplatin; group IV was 
pretreated with acetyl L-carnitine before cisplatin intraperitoneal injection.  After 
72h of cisplatin injection uterine tissue was removed. Histological and 
immunohistochemical investigations were performed, respectively.  
Results: We found that the number of TUNEL and caspases positive cells were 
increased in the endometrial epithelium, subepithelial connective tissue, 
endometrial glands and stroma in group III compare to the other groups. 
Furthermore inflammation and edema were observed in uterus of rats in group 
III. 
Conclusion: We can concluded that pretreatment of acetyl L-carnitine 
administration has protective effect on histological alteration of uterus caused 
by cisplatin. 
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ÖZET 
 
Amaç: Bu çalışmanın amacı, asetil L-karnitinin, sisplatinin neden olduğu uterus 
hasarına karşı profilaktik etkilerini araştırmaktır. 
Yöntem: Yirmi dört adet Wistar albino cinsi dişi sıçanlar dört gruba ayrıldı: 1. 
gruba (kontrol) salin uygulaması yapıldı; 2. gruba asetil L-karnitin uygulaması 
yapıldı; 3. gruba sisplatin uygulaması yapıldı; 4. grup ise sisplatinin 
intraperitoneal enjeksiyonu öncesinde asetil L-karnitin ile ön tedaviye tabi 
tutuldu. Sisplatin enjeksiyonundan 72 saat sonra uterus dokusu çıkarıldı. 
Histolojik ve immünohistokimyasal incelemeler yapıldı. 
Bulgular: TUNEL ve kaspaz pozitif hücre sayılarının, diğer gruplara göre 3. grupta 
endometriyal epitelde, subepitelyal bağ dokusunda, endometriyal bezlerde ve 
stromada arttığını bulduk. Ayrıca 3. Gruptaki ratların uterusunda inflamasyon ve 
ödem gözlenmiştir. 
Sonuç: Asetil L-karnitin ön tedavi uygulamasının, sisplatin kaynaklı uterus 
histolojisinin değişikliği üzerinde koruyucu etkisi olduğu sonucuna vardık. 
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INTRODUCTION 
 
The anticancer drugs, have toxic effects on various organs and tissues, 
affecting the life quality such as growth problems, ovarian and testicular damage, 
cardiovascular problems, neuronal developmental problems, secondary malign 
tumors with decreasing cancer-related mortality rates (1-4). 
Cisplatin is one of the broad spectrum antineoplastic agents commonly used 
in the treatment of many cancer types. Cisplatin causes toxicity with many 
mechanisms such as hypoxia, mitochondrial damage, inflammation and fibrosis. 
When cisplatin is taken into the cell, many signaling pathways are activated and 
apoptosis or necrosis is observed in the cell, besides preventing the proliferation 
of cancerous cells as well as causing damage to healthy cells due to their 
structural similarities (5). Cisplatin causes reduction of cellular and nuclear 
synthetic activity of DNA and RNA in particular, and also damages mitochondrial 
DNA. Numerous cisplatin mechanisms have been proposed, including 
cytotoxicity induced by reactive oxygen species, activation of mitogen-activated 
protein kinase intracellular signaling pathways, caspases and TNF mediated 
apoptosis, inhibition of ATPase and other intracellular enzymes. After the 
cisplatin treatment gonadotoxicity is one of the major clinical side effects (6-9). 
New strategies have been developed to prevent the toxic effects of cisplatin, 
particularly by contributing to the production of free oxygen radicals, and 
antioxidants that protect against cell damage by neutralizing free radicals in 
terms of concurrent preventive treatments have been retained on premise 
approach (10).  
Carnitine is a vitamin-like compound with proven antioxidant properties that 
regulates the amount of acetylated Coenzyme (KoA), which allows the passage 
of long chain fatty acids to the mitochondrial matrix to go to beta oxidation 
during the energy production of the cell, and plays a role in other cellular 
metabolic events. L- isoform of carnitine is synthesized endogenously and taken 
from outside. It is a protective agent which has a critical role in mitochondrial 
functions. L-carnitine, which is arrange the acilCoA / CoA rate and keep in toxic 
materials inside the mitochondria. Therefore,  systemic L-carnitine treatment 
with cisplatin injection, may prevent the toxic effects by occuring cisplatin (11). 
Acetyl L-carnitine is an analogue of short chain ester of L-carnitine (12).  
Experimental studies have reported that carnitine treatment decreased the 
hepatotoxicity, cardiotoxicity, neurotoxicity and intestine toxicity which are 
cause of cisplatin injection (13-15). Studies in different cell types showed that 
carnitine is a potent antioxidant to prevent cell membrane permeability changes, 
apoptosis, mitochondrial dysfunction and lipid peroxidation (15). 
So, we aimed to investigate the protective effects of acetyl L-carnitine on 
cisplatin-induced adverse effects in uterus in our study. 
 
MATERIAL and METHODS 
 
Animals and experimental design 
Animals were acquired from the Laboratory Animal Breeding and Experimental 
Research Centre of Gazi University (GUDAM) and the protocol of the experiment 
was approved by Ethical Committee of Gazi University and were performed in 
accordance with the guidelines for the care and use of laboratory animals.  
Twenty-four female Wistar albino rats, weighing 200–250 g, were used for the 
study and were maintained under standart laboratory conditions (12 hr 
light/dark cycle, 20±2°C, relative humidity 50±15%) for three days. Standard food 
pellets and tap water were provided ad libitum. 
The animals were randomly divided into four groups each containing six rats: 
Group I (control) treated with saline, Group II treated with acetyl L-carnitine (200 
mg/kg), Group III treated with cisplatin (13 mg/kg) and Group IV pre-treated with 
acetyl L-carnitine (200 mg/kg) before cisplatin (13 mg/kg) treatment. Acetyl L-
carnitine (Sigma®, Germany, 600 mg dissolved in saline solution 3 mL) was 
injected subcutaneously into the rats in Groups II and IV and simultaneously 
saline was injected subcutaneously at the same dose into the rats in Groups I and 
III. Cisplatin (Cisplatin-Ebewe®,Liba, Istanbul, Turkey) was injected 30 min after 
acetyl L-carnitine/saline injection via intraperitoneal infusion for one hour only 
the first day into the rats in Groups III and IV. The doses and application methods 
of cisplatin and acetyl L-carnitine were decided on the basis of the clinical doses 
converted into animal doses using surface area and as proposed by Tufekci et al 
and Coskun et al (16, 17). The intervention stated above lasted to the end of the 
experiment. After 72 h cisplatin treatment (the fourth day) all rats were 
euthanized by ketamine hydrochloride (40 mg/kg) (Ketalar, Eczacibasi, Istanbul, 
Turkey) and xylazine hydrochloride (5 mg/kg) (Rompun, Bayer, Istanbul, Turkey) 
and uterine tissues were taken for the histological analysis. 
 
Histological investigations  
Uterine tissue samples were fixed in 10% neutral buffered formalin and 
embedded with parafin after routine histological procedures were fulfilled for 
histological analysis. Paraffin sections of formalin-fixed tissue were sectioned at 
a thickness of 4 µm for staining with hematoxylin and eosin (H&E). The slides 
were examined by using a light microscope (Leica DM 4000, Germany).  
 
TUNEL assay 
The terminal deoxynucleotidyl transferase dUTP nick endlabelling (TUNEL) 
method was performed  to assess DNA fragmentation. 4 μm-thick uterine tissue 
cross sections were incubated at 61°C. After deparaffinisation, sections were 
incubated with 20 μg/mL proteinase K (Roche Diagnostics, GmbH) at 37°C for 25 
min and any endogenous peroxidase activity was blocked by incubating in 3% 
hydrogen peroxide (Lab Vision, Fremont, USA) for 15 min. TUNEL kit (450 μL label 
solution, 50 μL enzyme solution) (Roche, In Situ Cell Death Detection Kit) was 
incubated with for 60 min at 37˚C in a humid and dark environment. The sections 
were incubated with converter POD (Roche Diagnostics, Indianapolis, USA) 
solution in a humid environment at 37˚C for 30 min. Subsequent staining with 
diaminobenzidine substrate solution (DAB) was used to determine TUNEL-
positive cells. Mayer’s haematoxylin was used as a background stain. Cross-
sections were evaluated under a light microscope (Leica DM 4000 Germany) 
using a computer-supported imaging system to take photos using the Leica Q Vin 
3 program (Wetzlar, Germany). 
 
Immunohistochemical procedure  
The avidin-biotin peroxidase method was performed for the 
immunohistochemical studies to investigate anti-caspase 3, 8 and 9 activities. 
After deparaffinisation, to expose receptor areas within the tissue that were 
blocked by formaldehyde, tissues were exposed to antigen retrieval in citrate 
buffer (pH 6.0) (Lab Vision, Fremont, USA) under a high temperature. Following 
the antigen retrieval procedure, the tissues were allowed to cool down at room 
temperature for 20 min and then rinsed with distilled water and exposed to 3% 
hydrogen peroxide (Lab Vision, Fremont, USA) for 15 min. Ultra V block (Lab 
Vision, Thermo Scientific) was applied for 5 min to prevent nonspecific binding. 
Following the blocking stage, sections were kept at room temperature for 45 min 
without being washed and exposed to anti-caspase-9 antibody (caspase-9/LAP6 
Ab-4, Rabbit Polyclonal) (Labvision, Thermo Scientific, Fremont), anti- cleaved 
caspase-3 antibody (caspase 3 (CPP32) Ab-4, Rabbit Polyclonal) (Labvision, 
Thermo Scientific, Fremont) and primer antibodies that were diluted 1:100. An 
anti-caspase-8 primer antibody (Rabbit Polyclonal, Labvision, Thermo Scientific, 
Fremont) was incubated overnight at +4˚C. Peroxidase-conjugated secondary 
antibody (Lab Vision, Thermo Scientific) was applied for 10 min. and reacted for 
20 min with streptavidin peroxidase enzyme (Lab Vision, Thermo Scientific) 
complex for 10 min. Color reaction was developed by incubation with DAB 
(Spring Bioscience)  for approximately 5-10 min to ensure an immune reaction. 
Mayer’s haematoxylin was used as a background stain. Cross-sections were 
evaluated with imaging system.  
 
Statistical analyses  
All statistical analyses were performed with Statistical Package for the Social 
Sciences (SPSS) statistical software (SPSS for Windows, version 16.0). Results are 
presented as mean ± standart deviation. P values of < 0.05 were considered to 
indicate statistical significance. The differences between rat weights were 
statistically evaluated using the Wilcoxon signed rank test. TUNEL-positive and 
caspase 3, 8 and 9 immunreactive cells were counted in 10 randomly selected 
areas (magnification x400) on uterine walls in six cross-sections from each group. 
Statistical differences between the means of the various groups were evaluated 
using the Mann Whitney U test. 
 
RESULTS  
 
Histological results 
We found that the rat uterus showed normal histological structures with H&E 
staining in group I (Figure 1a,b) and group II (Figure 1c,d). We observed the 
inflammatory cell infiltration in the endometrial epithelium, intraepithelial area 
and subepithelial connective tissue in uterus of rats from group III. Cellular debris 
in the lumen of the endometrial glands and edema in the subepithelial 
connective tissue were observed in group III.  
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Furthermore we observed the epithelium that lined the surface of uterus was 
the single squamous epithelium (Figure 1e,f). When we compare the group IV 
and group III, intraepithelial lymphocytes were rarely observed in the lumen of 
endometrial glands and subepithelial edema was not observed in the 
endometrium of uterus in group IV (Figure 1g,h). 
  
Figure 1. Normal microscopic apperance of the uterine tissue in group I (a,b) 
 and group II (c,d). Group III showed inflammatory cell infiltration (red arrows) 
(e), subepithelial edema (yellow arrows) and squamous epithelium (green 
arrows) (f). While group IV showed similar results to control group (g,h) 
 (Magnification: x100; x400; H&E).  
  
 
 
 
TUNEL results 
Mean values of the TUNEL-positive cells were determined in uterus 
epithelium, endometrial glands and endometrial stroma. The number of TUNEL-
positive cells were significantly increased in group III (between groups I-III: 
pepithelium=0.004, pgland=0.004, pstroma=0.008; between groups II-III: pepithelium=0.004, 
pgland=0.004, pstroma=0.006; between groups IV-III; pepithelium=0.004, pgland=0.004, 
pstroma=0.030) compare to other groups. When the mean number of cells with 
DNA fragmentation was analyzed in group IV,  the results were similar with group 
I and II in endometrial epithelium and endometrial glands (p>0.005).On the other 
hand the mean number of cells with DNA fragmentation was significantly 
increased in the uterus stroma (between groups IV-I: pepitelium=0.804, pgland=0.806, 
pstroma=0.029; and between groups IV-II: pepithelium=0.804, pgland=0.743, 
pstroma=0.019). Additionaly, the mean number of cells with DNA fragmentation in 
group IV were lower than in group III (pepithelium=0.004, pgland=0.004, pstroma=0.030) 
(Figure 2, 3). 
 
Figure 3. The mean number of TUNEL positive cells 
 
Immunohistochemical results   
We evaluated cytoplasmic reactivity of caspase 8 in uterine epithelium, gland 
epithelium and stroma. When we compare with group I and III (pepithelium=0.004, 
pgland=0.004 pstroma=0.004)  and group I and IV (pepithelium=0.004, pgland=0.006, 
pstroma=0.006) the results were statistically significant. The number of caspase 8-
positive cells was higher in group III and IV than group I. Caspase-8 activity was 
significantly higher in Group III compare with group IV (pepithelium=0.004, 
pgland=0.004, pstroma=0.004) (Figure 2, 4). 
 
 
 
Figure 4. The mean number of caspase-8 positive cells 
 
Figure 2. Immunohistochemical and apoptotic findings of all the groups 
(DAB, Haematoxylin) (Magnification, x400). 
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These findings suggest that cisplatin may be induce apoptosis that was 
triggered by caspase 8 in extrinsic pathway and also pretreatment of acetyl L-
carnitine may be partially prevent apoptosis triggered by caspase 8. 
We evaluated cytoplasmic reactivity of caspase 9 in uterine epithelium, gland 
epithelium and stroma. When group I was compare with group III 
(pepithelium=0.004, pgland=0.004, pstroma=0.004)  and group IV (pepithelium=0.012, 
pgland=0.005, pstroma=0.029) the results were statistically significant. The number 
of caspase 9-positive cells was higher in group III and IV than group I. Caspase-9 
activity was significantly higher in Group III compare with group IV 
(pepithelium=0.004, pgland=0.004, pstroma=0.004) (Figure 2, 5). 
 
 
Figure 5. The mean number of caspase-9 positive cells 
 
These findings suggest that the number of proapoptotic cells that leads to 
apoptosis by the caspase 8-induced extrinsic pathway was higher than that 
induced by the caspase 9 intrinsic pathway. Also, acetyl L-carnitine pretreatment 
partially prevent triggered apoptosis. 
We evaluated cytoplasmic and nuclear reactivity of caspase 3 in uterine 
epithelium, gland epithelium and stroma. Caspase 3 activity was significantly 
higher in group III compare with group I (pepithelium=0.004, pgland=0.004, 
pstroma=0.225). On the other hand, there was no statistically significant difference 
between group IV and group I (pepithelium=0.197, pgland=0.168, pstroma=0.936). 
Caspase 3 activity was significantly higher in group III compare with group IV 
(pepithelium=0.004, pgland=0.004, pstroma=0.872) (Figure 2, 6). 
 
 
Figure 6. The mean number of caspase-3 positive cells  
 
These findings suggest that cisplatin treatment initiated apoptotic process by 
activated pro-caspase 3 in endometrial epithelium and gland epithelium. Also 
acetyl L-carnitine pretereatment partially prevent triggered apoptosis.  
 
DISCUSSION 
 
Chemotherapeutic agents used in modern cancer treatments are one of the 
most promising treatment methods nowadays but in long term uses they may 
cause growth problems, cardiovascular problems, neuronal developmental 
problems, secondary malign tumors, destroying the balance between oxidants 
and antioxidants. In this case, after treatment quality of life is decreased (1-4). 
Cisplatin, which is an antineoplastic agent, is effective against various 
neoplasms such as urogenital system carcinomas, central nervous system 
tumors, advanced ovarian cancers, head, neck, testis, bladder and small cell lung 
tumors (18).  
 
 
The main target of cisplatin is nuclear DNA. Also, other intracellular 
components such as cysteine and methionine are also closely related. DNA-
cisplatin adduction may lead to delayed cell cycle progression or inhibition of 
DNA repair. Cisplatin-induced apoptosis includes many intracellular signal 
pathways, including activated protein kinase cascades (6). 
Besides these effects againts on tumor cells, cisplatin has known a dose-
limiting side effects such as nephrotoxicity, neuropathy, ototoxicity and 
gonadotoxicity in long-term use,  due to structural similarities between healty 
and tumor cells (5, 19, 20, 21). Especially formation of reactive oxygen radicals 
(ROS) and mitochondrial oxidative damage play a critical role to development of 
cisplatin toxicity (19).  
In this study, we investigated the toxic effects of cisplatin on uterus. The toxic 
effects of cisplatin was demonstrated in various tissue, it was administered 
intraperitoneally (13 mg/kg/dose during one hour) to rats. After cisplatin 
treatment our results showed that, endometrial epithelial cells lost their 
prismatic cell shape form and turned into squamous epithelium. Infiltration of 
inflammatory cells were observed in subepithelial area, intraepithelial area and 
subepithelial connective tissue. Furthermore cellular debris in the lumen of the 
endometrial glands and edema in the subepithelial connective tissue were seen. 
Sugiyama et al.  found that, while cisplatin reducing the levels of GSSH and free 
radical scavenging enzymes such as SOD, GSH-Px at tissue, it is leading to an 
increase in oxygen radicals, especially O2- (22). Another in vivo studies with rats 
showed that cisplatin reduce the function of some antioxidant enzymes such as 
SOD and GSH-Px, it has also decrease the level of GSSH, which plays a 
conservative role in reactive oxygen species. This increase in reactive oxygen 
species can also lead to DNA damage and lipid peroxidation in cell membrane 
(23). 
David R. et al. were administered cyclophosphamide, a cisplatin-like agent, to 
the mice. After the injection they were determined decrease of uterine tissue 
weight, plasma estradiol level and endometrial glands and showed vacuolation 
of stroma. During the experiment lack of plasma estradiol levels caused atrophy 
at uterin tissue. At the end of study plasma estradiol level has been returned to 
normal but no change in uterine weight depending on the decline of the cells in 
the basal layer of the endometrium, in the connective tissue and myometrium.   
As a result of the research, it was determined that cyclophosphamide directly 
affects both the ovary and the uterus (24). Coskun et al. assessed the effects of 
cisplatin treatment. Researchers reported that rat weights were decreased after 
cisplatin injection (17). Morover, Iraz et al. concluded that the toxic effects 
induced by cisplatin administration include a decrease in SOD and GSH-Px 
activity, also decrease rat weights (25). As supported by previous study, we found 
that cisplatin affects histomorphologically at uterine structure and rat weights 
like cyclophosphamide.  
Many studies have been carried out on protective treatments with free radical 
scavengers because cisplatin is caused an increase of free oxygen radicals (26). 
These studies have shown that antioxidants play a critical role in toxicity and is 
understood their importance (10). 
L-carnitine is one of the significant antioxidant and free radical scavenger. 
Some studies have been notified that it increased the antioxidant effects of 
askorbik asit, glutatyon ve E vitamini and reduced the accumulation of lipofuscin 
which is known peroxidative marker in neurons (27). Moreover, in a study 
reported that L-carnitine partially protected the DNA (28). 
Coskun et al. have observed the protective effects of L-carnitine against the 
damage on testicular tissue (17). Moreover Chang et al. administered cisplatin to 
rats at a dose of 5 mg/kg intraperitoneal to induce nephrotoxicity and reported 
that acetyl L-carnitine administered subcutaneously at a dose of 200 mg/kg 
prevented nephrotoxicity (29).  
As supported by previous studies, we evaluated prophylactic effects of acetyl 
L-carnitine administration to rats at a dose of 200 mg/kg against cisplatin toxicity 
on uterine tissue prophylactic administration of acetyl L-carnitine after cisplatin 
injection. We found that epithelial cells are typical of uterine endometrium 
epithelial cell formation, subepithelial connective tissue edema and 
intraepithelial/subepithelial neutrophilic inflammation are not developed. In our 
study observed that prophylactic effects of acetyl L-carnitine administration on 
uterine tissue protect against cisplatin toxicity. 
In vitro studies have shown that cisplatin increases apoptosis causing damage 
to primordial follicles. In addition, oocyte, granulosa and theca cell damage and 
apoptosis in primordial follicles resulting in chemotherapy can be seen. Saribas 
et al. concluded that cisplatin caused damage to the tubal tissue and that these 
injuries were prevented by pretreatment with acetyl L-carnitine (30). Zhang et al. 
determined that cisplatin administration at Balb/c mice triggered apoptosis on 
germ cells.  
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As supported by this study while cisplatin change the maturation periods of 
spermatogenic series cells, causing azospermia by reducing spermatogenesis. 
These results obvious that cisplatin may affects fertility (19). 
Cytoplasmic caspase release can be determined by immunohistochemical 
methods using antibodies against caspases, which are apoptotic elements, to 
detect the presence of apoptosis in a tissue. Caspases 8 and 9, and activated 
caspase 3 an important agent in apoptosis, to initiate irreversible apoptosis. 
Another method to determine the apoptosis is TUNEL. This method is shown the 
cell with DNA fragmentation. TUNEL reaction is the most popular method of 
recent toxicity studies since it allows the early identification of apoptotic cells in 
apoptosis (31).  
Our study also showed that apoptosis triggered by cisplatin in the uterus was 
prevented by prophylactic administration of acetyl L-carnitine. This finding was 
assessed by the TUNEL method, in which the number of cells with DNA 
fragmentation was determined. In addition, the results of marking anti-caspase 
3, 8 and 9 antibodies were evaluated statistically. In the TUNEL results, group IV 
findings were similar to the control group for uterine epithelium and gland 
epithelium. Group IV findings were similar to the control group when evaluated 
for stromal involvement. The number of cytoplasmic and nuclear staining of the 
caspase 3-labeled uterine epithelial cells and glandular epithelial cells in the 
group IV was statistically significant compared to the cell numbers in the cisplatin 
group. When stromal involvement was evaluated; the difference between the 
group II and group III was evaluated as meaningful, while the difference between 
the other groups was not significant.  
When marked with caspase 8, the number of proapoptotic cells in the uterine 
epithelium, gland epithelium, and stroma in the group II decreased significantly 
compared to the cell numbers in the group III. In addition, the number of cells 
showing caspase 9 involvement in the pre-surgical group III with group II was 
lower in uterine epithelium, gland epithelium and stroma than in the cisplatin 
group. However, when the results of caspase 8 and caspase 9 were compared, it 
was determined that the numbers of proapoptotic cells leading to apoptosis by 
the extrinsic pathway were higher than those induced by the intrinsic pathway. 
Thus, histomorphological and apoptotic effects of cisplatin on uterine tissue 
were investigated; it is thought that these effects may be protective of the 
application of prophylactic acetyl L-carnitine.  Our study aimed to protect the 
reproductive system in cancer patients. Similar studies with such treatment 
approaches will be promising in terms of quality survival for cancer patients in 
long-term survival. 
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